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1. Introduction
  Malaria represents a major health and social-economic 
problems in Tanzania (with a population of 35.6 million 
people). In Tanzania malaria ranks as number one in 
terms of morbidity and mortality. Malaria management 
has remained the mainstay for mitigating complications of 
mild and severe malaria including convulsions and death 
especially in underfive children. Unfortunately malaria 
management in Tanzania has been hampered significantly 
by rapid development and spread of resistance to first line 
drugs which began with chloroquine (CQ) and latter to 
sulphadoxine-pyrimethamine combinations (SP). Because 
of resistance of Plasmodium falciparum (P. falciparum) to 
SP, Tanzania Malaria Control Program has again replaced 
SP with Artemesin Combination Treatment [artemisinin-
based combination therapy(ACT)] in this case the drug of 
choice is artemesin and lumefantrine fixed combination 
[artemesinin-lumefantrine(ALU)] from November 2006.
  Malaria kills one child every 30 seconds in Sub-Saharan 
Africa and more than 3 000 chidren under 5 years per 
day[1,2]. African children under 5 years are chronic victims 
of malaria, suffering an average of six bouts a year. Fatally 
afflicted children often die in less than 72 hours after 
developing symptoms which are not correctly attended or if 
there are delays of any kind.
  About 30% or more of the malarial disease mortality 
can be avoided if children can be properly diagnosed, 
treated with correct effective antimalarial drugs, sleep 
regularly under treated bed nets containing recommended 
insecticides such as pyrethroids or long lasting insecticide 
treated nets (LLTNs).
  Several studies have shown a high degree of non-
compliance to previously used antimalarials (such as CQ). 
Unless the barriers and influencing factors are elucidated 
and addressed, new more effective drugs such as ACT 
could lead to ineffective treatment and resistance. It is 
known that over half of caretakers practice self medication 
when their children suffer from fever[3,4]. This practice 
may expose parasites to sub-therapeutic doses of ACT 
with consequences of developing Plasmodium resistance 
and increasing morbidity and mortality due to malaria. 
Furthermore, as ACT is expensive and if resistance develops 
then sub-African countries will have no other better drug 
options as these countries can not afford more expensive 
drugs and if this happens it will be catastrophic to most 
people living in malaria endemic countries. Thus, there is a 
need to preserve the shelf-life of ACT to delay resistance.
  Even though resistance to antimalarial drug is posing 
major problems, malaria is still a curable and preventable 
disease, not an inevitable burden. Thus, it is fundamental 
to control malaria by the case management through early 
diagnosis, prompt and correct treatment in sub-Saharan 
countries including Tanzania.
  It is therefore, a basic right of the affected populations to 
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have access to affordable, safe and efficacious antimalarials. 
Furthermore, antimalarials need to be available wherever 
malaria occurs. Children and pregnant women, on whom 
malaria has its greatest impact in most of the world are 
especially important and should be targeted.
  In many countries of sub-Saharan Africa (SSA) most cases 
of malaria are diagnosed presumptively based on fever or 
body hotness and are treated at home by private sector or 
traditional healers. The treatment offered is often incomplete 
and irrational through self treatment or self-medication. 
Thus, rational use of antimalarials can improve medication 
compliance. Everyone including community members 
within households should take the responsibility of malaria 
control and contribute to it. This is only possible if their 
awareness, perceptions and attitudes can be raised through 
educational interventions about malaria prevention and 
rational antimalarial drug use campaigns. 
2. Materials and methods  
  The study was carried out in Mkuranga district, Coast 
region of Tanzania mainland, where malaria is endemic, 
from January to April 2003.  The peak malaria season occurs 
in the months of November and June every year.   
  A total of 1 960 mothers/guardians from which 1 928 
children aged 6-59 months where obtained and included in 
the baseline survey. The demographic profiles of mothers/
guardians were:the mean age was 28 years, 55% had no 
education, 45% had primary education and only 1% had 
secondary education. Whereas, 53% of children under 5 
years were females and 47% were males.
  The administrative structure of the district formed the 
basis for a 3 stage stratified sampling procedure which was 
used for selecting wards, villages and households. A total 
of 10 villages out of 20 were randomly selected during this 
baseline survey. A complete list of wards, villages and 
households were obtained from the District Planning Officer 
(DPO) of Mkuranga District, Coast region.
2.1. Data and blood sample collection
  Semi-structured questionnaire consisted of open and 
closed ended questions including home stocking, home use, 
last fever episodes and treatment practices of underfives 
with malaria using CQ or SP. The questionnaires were 
translated into Swahili language and were pre-tested. All 
mothers of underfive childrenhad interviews in these 10 
study villages. The recall period was 2 weeks.
  After obtaining verbal consent from mothers or guardians, 
in every household with one child under five, the capillary 
blood sample was collected from every fifth child enrolled 
in the household survey. If a household had more than one 
children under five, the one who had suffered the most 
recent fever episode was selected to be taken capillary 
whole blood sample. Two separate settings of 100 毺L blood 
samples were taken from the same child.  A total of 200 
毺L of blood was taken for analysis of CQ and SP for each 
child. Blood samples were taken from a total of 117 children 
through a finger prick. All blood samples were dried on 
filter paper and analysed for determination of CQ and SP 
blood drug concentrations using a high performance liquid 
chromatography (HPLC).
2.2. Data analysis                     
  The results of questionnaire were analysed using software 
(Stat Soft Inc. Tulse USA). And the blood samples were 
analysed with HPLC methods for CQ and SP[5]. The accuracy 
for CQ was measured at 375 nm with a coefficient variation 
(CV) of 5.3% and accuracy at 451 毺M with a CV of 8.9% for 
sulfadoxine method. The limit of determination was 100 nM 
for CQ and 25 毺M for sulfadoxine, respectively. 
2.3. Laboratory investigations
  Thick and thin blood smears were taken and Giemsa 
stained for detection and determination of malaria parasites. 
The numbers of asexual parasites were counted against 200 
white blood cells (WBCs) in thick films. A blood film was 
considered negative when examination of 500 WBC fields 
did not show the presence of asexual forms of P. falciparum. 
2.4. Ethical approval
  Participation was voluntary and informed consent was 
obtained from all households. Ethical approval was 
obtained from the Tanzania Commission for Science and 
Technology (COSTECH)-Dar-es-Salaam, Tanzania, and 
also obtained from the Mkuranga district, Coast region 
administrative authorities, ward secretaries and leaders of 
the villages and harmlets. Community consent was sought 
during village meetings in all study villages and hamlets. 
During the following visits to individual households, 
caretakers were asked for their oral consent after receiving 
detailed information from the study physician about all 
risks and benefits of the study. They were informed that 
they could withdraw from the study at any time and without 
disadvantage. 
3. Results
  A total of 53% of the children were females and the average 
age in months for them was 29.6. And 47% of the children 
were males and the average age in months for them was 
30.0 years old.  The average age of mothers was 28.1 years 
old. 54.5% of the mothers or guardians were not educated, 
44.5% with primary education and only 1.0% of them with 
secondary education.
  The rate of fever or reported fever of children during the 
last 48 hours by their mothers or guardians was 70%. 90% 
of the children were undernourished during the study 
period.However, only 8 children out of 117 were found to 
have malaria parasites and most of them had normal body 
temperature of 36.7 曟. 
  Drug analysis showed out of these 117 samples 
only 8 children were found to have CQ and 13 had SP 
concentrations within their blood respectively.  However, 
none of these blood drug levels were above therapeutic 
ranges. At baseline, 26% of the study children had P. 
falciparum parasites detected in their blood smears. 
4. Discussion
  Malaria is a major public health and socio-economic 
problem in sub-Saharan countries including Tanzania. It is 
estimated that every year 300 to 500 million clinical cases 
of malaria occur[6], and about one million deaths result as a 
direct consequence of infection with P. falciparum[7]. 
  Our study findings show that malaria is common in the 
study area and it is highly reported by mothers/guardians. 
Since malaria is common in the area mothers/guardians 
over-reported the use of antimalarials like SP, but when 
blood analysis was done all (13) under fives children had 
sub-therapeutic drug levels of SP and CQ, respectively. Use 
of sub-therapeutic antimalarial doses has been reported to 
favour development of CQ drug resistance by parasites[8]. 
That means either they were not knowledgeable, and the 
new drug by then (SP) was not yet popular and hence not 
used frequently. People did not like that drug and hence 
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used other antimalarials besides SP or did not remember of 
what kind of drugs they had administered within two weeks. 
It has been reported from the same study region that SP was 
negatively perceived by some community members within 
households when it was 8 months old after introduction in 
Kibaha district[9].  
  Unfortunately, we never asked for the other drug 
alternatives they might have used at that time. It is quite 
clear that CQ was phased out by the Ministry of Health 
in July, 2001 and hence CQ was not in the market. 
Furthermore, most children were undernourished and 
underweight. Poor nutrition among children makes them 
prone to infections and their body immune system is weak 
because they are not fed with nutritious foods. Apart from 
being prone to infections, both poor nutrition and infections 
affect children’s growth.    
  It is reported that malaria situation is deteriorating every 
year in Tanzania[10], as the disease burden increases[1], in 
relation to the malaria related mortality. Children under 
the age of five and pregnant women are subject to more 
episodes of clinical malaria, cerebral malaria, anaemia[11], 
leading to high mortality rate[12]. This situation has been 
worsened by the development and widespread of resistance 
of P. falciparum to CQ and the declining efficacy of SP that 
has severely compromised effective treatment and malaria 
control programs. Despite these drawbacks, SP is still used 
for intermittent malaria treatment for pregnant women (IPTp) 
and infants (IPTi) in Tanzania mainland[13], Kenya[14] and 
Malawi[8]. 
  In holo-endemic areas of Tanzania, early malaria diagnosis, 
correct and prompt effective treatment remains the mainstay 
of malaria control strategy[15]. Thus there is a strong need for 
improved understanding of how to optimize malaria treatment 
policies as to prevent/minimize development and spread 
of drug resistant malaria including monitoring side effects 
related to any newly introduced antimalarial drugs like ALU 
therapy in Tanzania. As drug failure and drug related effects 
may compromise compliance.
  Fixed combination ACT, is a new strategy for malaria 
treatment after phasing out SP in Tanzania and other sub-
Saharan countries. The effectiveness of ACT is based on 
the hypothesis that two or more components of different 
mechanisms of action protect each other from development 
of resistance, simultaneously enhancing the efficacy and 
promoting compliance. However, irrational use of drugs 
within households/rural communities in terms of taking 
inadequate doses, and sometimes not completing doses 
when patients felt better are some of the factors which could 
encourage selection of Plasmodium resistance strains to 
any newly developed and introduced antimalarial including 
ACT[4,16]. Lack of diagnostic equipment like microscopes 
and reagents for the diagnosis of malaria often lack in 
dispensaries and health centers which cater for the health 
care of the majority of Tanzanians[4]. 
  In order to protect the life span of a new antimalarial 
drugs, such as ACT, or popularly known as ALU which 
has a complex regimen as compared to its predecessor SP 
which was a single dose administered by directly observed 
therapy(DOT), improving education of patients especially 
mothers/guardians of underfive children within rural 
communities/households about rational use of antimalarials 
including doses, duration of treatment and consequences of 
incompleting doses is important. The impact of this strategy 
will be evaluated by assessing malaria morbidity and 
mortality in the study areas and compared to control areas 
where no such educational approach is made. Once such 
interventions are made and if it is found to have positive 
impact then the National Malaria Control Program within 
the Ministry of Heath should scale up country wide. 
  Thus, community interventions are urgently needed 
in rural communities and should specifically target the 
households nucleus on early malaria fever recognition and 
provision of correct recommended antimalarials for the sick 
underfive children. However, sadly there was an increase 
in underweight and undernourishment in our study areas. 
This can be explained by presence of malaria in the area 
and poverty which is associated with poor nutrition in these 
underfive children.
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